Skip to main content
  • ENG
  • FR

Search form

Medicines for Malaria Venture

Developing antimalarials to save lives

  • Research & Development
    • MMV's pipeline of antimalarial drugs
    • R&D areas of work
      • Next-generation medicines
      • Products for key populations
    • Working with regulators
    • Information for scientists
      • Malaria online course
      • Global health compound design webinars
      • Call for proposals
      • TPPs & TCPs
      • Learning resources for scientists
    • Project of the year award
    • Computational chemistry
    • R&D challenges
  • Access
    • Products & projects
    • Antimalarial drug availability
    • Areas of work
      • Supporting introduction
      • Enhancing reach
      • Informing R&D
      • Gathering market intelligence
    • Antimalarial drug toolkits
      • Artesunate injection dosage & administration
      • Artesunate rectal capsules tool kit
      • Seasonal Malaria Chemoprevention tool kit
    • Access challenges
  • Partnering
    • The PDP model
    • Our partner network
    • Our donors
      • Current donors
      • Past donors
    • Donate to MMV
    • Intellectual property rights (IPR)
    • Clinical centre partners by country
  • Our impact
    • Milestones
    • Malaria stories from the field
    • Antimalarial drugs for children
    • Gender equity
    • Global health security
      • Antimicrobial resistance to antimalarials
      • Malaria and COVID-19
  • About us
    • What we do
      • An overview of our work
      • Our strategic focus
      • Our history
    • People & governance
      • Staff bios
      • Staff interviews
      • Board of Directors
      • MMV North America Board
      • Expert Scientific Advisory Committee
      • Access & Product Management Advisory Committee
      • Global Safety Board
    • Work with us
      • Jobs
      • RFPs/RFIs
    • Policies
    • Diversity at MMV
    • Funding and expenditure
    • FAQs
    • Contact us
  • Malaria & medicines
    • Definitions and symptoms
    • 5 species of Plasmodium parasites
    • Lifecycle of malaria parasite
    • Malaria facts & statistics
    • Malaria treatment
    • History of antimalarial drugs
  • Newsroom
    • News & Press Releases
    • Audio
      • Media interviews
      • Speaking of Malaria podcast
    • Films
    • Infographics
    • Interviews
    • Image slideshows
    • Publications
    • Events
  • MMV Open
    • The Global Health Priority Box
      • About the Global Health Priority Box
      • Supporting information
      • Request the Global Health Priority Box
      • Terms & conditions
    • Malaria Libre
      • Malaria Libre open innovation platform
      • Participate in Malaria Libre
      • Malaria Libre data repository
    • MMVSola
      • About MMVSola
    • Pandemic Response Box
      • About the Pandemic Response Box
      • Request the Pandemic Response Box
      • Supporting information
      • Terms & conditions
    • COVID Box
      • About the COVID Box
      • Supporting information
      • COVID Box terms and conditions
    • Archived projects
      • Pathogen Box
      • Malaria Box
    • MMV Open Team
    • Contact us
  • An open tool for early PK and antimalarial dose prediction

  • Living happily, protected from malaria. Read Tenin's story.

    Photo: Toby Madden/MMV
  • Take a look at our infographic on blocking malaria transmission.

    JumpStory JumpStory

Milestones

  • .
    150+ active partners working to defeat malaria

    Find out more

  • .
    12 compounds in clinical development

    Find out more

  • .
    USD1 = USD 3.5 investment impact

    Find out more

Home

News

Image of MMV CEO David Reddy

A message from MMV's CEO, David Reddy

46 million reasons and more to celebrate

16 Dec 2022
News story

Medicines for Malaria Venture and the Africa CDC sign Memorandum of Understanding to support African manufacturers

15 Dec 2022
Press release

According to WHO’s latest World Malaria Report the malaria burden remained stable in 2021 despite the pandemic and threats such as drug resistance 

Holding the line against malaria in 2021 despite ongoing challenges

08 Dec 2022
News story
Midwife Amichia Solange & Angelica Konate outside their health centre in Cote d'Ivoire

Meta-analysis supported by MMV, WHO, WWARN with funding from BMGF contributes to the WHO recommendation of artemisinin-based combination therapy artemether-lumefantrine 

WHO gives ‘strong recommendation’ supporting use of antimalarial drug to treat pregnant women in the first trimester

28 Nov 2022
News story
View all news

Defeating malaria together

  • Discover MMV's image slideshows

  • Films and animations

  • Open source research

Featured resources

  • Contribute to defeating malaria

    Over the last two years, the world’s focus has been on fighting Sars-CoV-2 and bringing us out of the most significant viral pandemic in over a century. MMV now needs your help to find new antimalarial drug candidates.

    Sep 2022
    Publication
  • MMV At a glance

    The MMV at a glance highlights our unique partnership model, the growth of our portfolio and the increasing impact of our access work. 

    Sep 2022
  • Fighting malaria from Geneva

    Geneva is considered the world's health capital. The close-knit nature of the cooperation between various international stakeholders is demonstrated by the example of the fight against malaria.

    Sep 2022
    Publication

Events

There are currently no upcoming events.

View past events
  • RSS subscribe
    Printer friendly

Follow us

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Subscribe

Previous newsletters

Contact us

  • Tel: +41 22 555 03 00

    • Message us
    • Office directions
© MMV 2023
Website by Manta Ray Media
  • Glossary
  • Disclaimer
  • Privacy
  • Sitemap